Drug Interactions With Phosphodiesterase-5 Inhibitors Used for the Treatment of Erectile Dysfunction or Pulmonary Hypertension

被引：85
|
作者：
Schwartz, Bryan G. [1 ]
Kloner, Robert A. [1 ,2 ]
机构：
[1] Hosp Good Samaritan, Inst Heart, Los Angeles, CA 90017 USA
[2] Univ So Calif, Keck Sch Med, Div Cardiovasc Med, Dept Internal Med, Los Angeles, CA 90033 USA
来源：
CIRCULATION | 2010年 / 122卷 / 01期
关键词：
drug combinations; nitroglycerin; pharmacokinetics; sex; vasodilation; HEALTHY MALE-SUBJECTS; INHALED NITRIC-OXIDE; ARTERIAL-HYPERTENSION; SILDENAFIL CITRATE; ORAL SILDENAFIL; CLINICAL-TRIALS; PHARMACOKINETIC INTERACTIONS; HEMODYNAMIC INTERACTION; CARDIOVASCULAR SAFETY; IN-VITRO;
D O I：
10.1161/CIRCULATIONAHA.110.944603
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：88 / 95
页数：8
相关论文
共 50 条
  • [1] Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension
    Gur, Serap
    Kadowitz, Philip J.
    Gokce, Ahmet
    Sikka, Suresh C.
    Lokman, Utku
    Hellstrom, Wayne J. G.
    [J]. CURRENT DRUG METABOLISM, 2013, 14 (02) : 265 - 269
  • [2] COUPLE SATISFACTION TO THE TREATMENT OF ERECTILE DYSFUNCTION WITH PHOSPHODIESTERASE-5 INHIBITORS
    Jiann, Bang Ping
    Huang, S. T.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 105 - 106
  • [3] Phosphodiesterase-5 inhibitors for male erectile dysfunction
    Sui, ZH
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (09) : 1373 - 1388
  • [4] Phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension
    Beltran-Gamez, Miguel E.
    Sandoval-Zarate, Julio
    Pulido, Tomas
    [J]. ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2015, 85 (03): : 215 - 224
  • [5] Treatment of pulmonary arterial hypertension with phosphodiesterase-5 inhibitors
    Ghofrani, H. A.
    Grimminger, F.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (49) : S311 - S314
  • [6] The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction
    Gupta, M
    Kovar, A
    Meibohm, B
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 987 - 1003
  • [7] Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction
    Kloner, RA
    [J]. CIRCULATION, 2004, 110 (19) : 3149 - 3155
  • [8] A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil
    Evans, Jeffery D.
    Hill, Stephen R.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 1159 - 1164
  • [9] A Review on Phosphodiesterase-5 Inhibitors as a Topical Therapy for Erectile Dysfunction
    Hamzehnejadi, Mohammadsadegh
    Tavakoli, Marziye Ranjbar
    Abiri, Ardavan
    Ghasempour, Ali
    Langarizadeh, Mohammad Amin
    Forootanfar, Hamid
    [J]. SEXUAL MEDICINE REVIEWS, 2022, 10 (03) : 376 - 391
  • [10] ASSESSING EXPERIENCE AND OUTCOMES WITH COMBINED USE OF PHOSPHODIESTERASE-5 INHIBITORS IN ERECTILE DYSFUNCTION TREATMENT
    McCarty, E.
    Hollow, K.
    Sadeghi-Nejad, H.
    Ashby, J.
    Goldmeier, D.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 317 - 317
12345